Asitri Dashboard
Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 33
Selected: 0
NCT ID | Title | ||
---|---|---|---|
NCT00003326 | Paclitaxel in Treating Patients With Metastatic, Recurrent, or Unresectable Cancer of the Esophagus | ||
NCT00003327 | Paclitaxel in Treating Patients With Recurrent or Refractory Head and Neck Cancer | ||
NCT00069966 | Pixantrone, Cytarabine, Methylprednisolone, and Cisplatin in Treating Patients With Aggressive Non-Hodgkin's Lymphoma in First Relapse | ||
NCT01308762 | A Clinical Study, to Evaluate the Safety and Tolerability of Intradermal IMM-101 in Adult Melanoma Cancer Patients | ||
NCT02372240 | A Study of VLX1570 and Dexamethasone in Myeloma Patients | ||
NCT00024362 | BBR 3464 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer That Cannot be Treated With Surgery | ||
NCT00003160 | Weekly Infusions of Paclitaxel in Treating Women With Stage III or Stage IV Ovarian Cancer Refractory to Paclitaxel and Platinum | ||
NCT01986426 | LTX-315 in Patients With Transdermally Accessible Tumours as Monotherapy or Combination With Ipilimumab or Pembrolizumab | ||
NCT02529930 | An Exploratory Safety and Immunogenicity Study of HPV16+ Immunotherapy VB10.16 in Women With HSIL; CIN 2/3) | ||
NCT02222363 | Study of Safety and Tolerability of VLX600, an Iron Chelator, in Patients With Refractory Advanced Solid Tumors | ||
NCT00039169 | BAY 59-8862 in Treating Patients With Advanced Kidney Cancer | ||
NCT00111904 | Paclitaxel in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer | ||
NCT01258816 | The Pharmacokinetics and Cardiac Properties of Elacytarabine (CP-4055) | ||
NCT04203641 | L-DOS47 Plus Doxorubicin in Advanced Pancreatic Cancer | ||
NCT04888312 | Safety and Efficacy of Mitazalimab in Combination With Chemotherapy in Pancreatic Cancer Patients | ||
NCT02309892 | A Dose Escalation Study of L-DOS47 in Recurrent or Metastatic Non-Squamous NSCLC | ||
NCT00024401 | DHA-Paclitaxel in Treating Patients With Metastatic Colorectal Cancer | ||
NCT02879669 | A Randomised Phase II Open-label Study With a Phase Ib Safety lead-in Cohort of ONCOS-102, an Immune-priming GM-CSF Coding Oncolytic Adenovirus, and Pemetrexed/Cisplatin in Patients With Unresectable Malignant Pleural Mesothelioma | ||
NCT03402841 | Multicentre Study of Olaparib Maintenance Monotherapy in Platinum Sensitive Relapsed Non gBRCAm Ovarian Cancer Patients | ||
NCT00024414 | DHA-Paclitaxel in Treating Patients With Metastatic Prostate Cancer | ||
NCT00024375 | DHA-Paclitaxel in Treating Patients With Metastatic Pancreatic Cancer | ||
NCT05280314 | Phase II Trial of Neoadjuvant and Adjuvant IO102-IO103 and Pembrolizumab KEYTRUDA® in Patients With Resectable Tumors | ||
NCT02272855 | A Study of Combination Treatment With HF10 and Ipilimumab in Patients With Unresectable or Metastatic Melanoma | ||
NCT04061421 | Active Myeloid Target Compound Combinations in MDS/MPN Overlap Syndromes Overlap Syndromes (ABNL-MARRO) | ||
NCT01035502 | A Study of Elacytarabine (CP-4055) Plus Idarubicin as Second Course Remission-Induction Therapy in Patients With Acute Myeloid Leukaemia | ||
NCT05732103 | A Study of CTX-712 in Relapsed/Refractory Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndromes | ||
NCT00039156 | BAY 59-8862 in Treating Patients With Refractory Non-Hodgkin's Lymphoma | ||
NCT00025688 | Paclitaxel With or Without Carboplatin in Treating Women With Metastatic Breast Cancer | ||
NCT00024388 | Chemotherapy in Treating Patients With Metastatic Kidney Cancer | ||
NCT05077709 | IO102-IO103 in Combination With Pembrolizumab as First-line Treatment for Patients With Metastatic NSCLC, SCCHN, or mUBC | ||
NCT03008187 | SEL24/MEN1703 in Patients With Acute Myeloid Leukemia | ||
NCT00014547 | BBR 3464 in Treating Patients With Metastatic Small Cell Lung Cancer That Has Not Responded to Previous Treatment | ||
NCT00053105 | Combination Chemotherapy in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma |